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ORIGINAL ARTICLEWell-Being and Chronic Disease Incidence: The
English Longitudinal Study of Ageing
Judith A. Okely, MSc, and Catharine R. Gale, PhDABSTRACT
Background: Previous research suggests that greater well-being may protect against onset of chronic disease. However, it is
unclear whether this association is similar across different types of disease.
Method:We used Cox proportional hazards regression to examine the prospective relationship between well-being (mea-
sured using the CASP-19 quality of life questionnaire) and incidence of arthritis, cancer, stroke, diabetes, myocardial infarc-
tion, and chronic lung disease over 8 years. The sample consisted of 8182 participants 50 years or older from the English
Longitudinal Study of Ageing.
Results:After adjustments for established risk factors, a standard deviation increase in CASP-19 score was associated with
a decrease in arthritis risk (hazard ratio [HR] = 0.89, 95% confidence interval [CI] = 0.83–0.96) and, in those younger
than 65 years, a decrease in diabetes risk (HR = 0.82, 95% CI = 0.70–0.95) and chronic lung disease risk (HR = 0.80,
95% CI = 0.66–0.97). Higher CASP-19 scores were associated with reduced risk for stroke and myocardial infarction; how-
ever, these associations were no longer significant after adjustments for established risk factors. No association was observed
for cancer incidence. An age interaction was observed for diabetes, myocardial infarction, and chronic lung disease, with a
stronger association between CASP-19 score and disease incidence at younger ages.
Conclusions: The extent of association between well-being and incident disease risk is not consistent across different
chronic diseases. Future studies should examine the cause of this variation.
Key words: CASP-19, chronic disease, well-being, aging.BMI = body mass index, CVD = cardiovascular disease, ELSA =
English Longitudinal Study of Ageing, SD = standard deviationINTRODUCTION
The relationship between emotion and physical healthhas inspired an extensive body of research (1). Numer-
ous studies have documented the link between negative
emotions and subsequent health outcomes including car-
diovascular disease, disability, and mortality (2–4). More
recently, the popularity of positive psychology and focus
on well-being in areas of public policy (5) have prompted
interest in a less researched aspect of the relation between
emotion and health, namely, the relationship between sub-
jective well-being and health outcomes.
Most research in the field of subjective well-being and
health has been informed by two distinct perspectives (6).
Hedonic well-being refers to the experience of positive emo-
tion such as pleasure or happiness. Eudaimonic well-beingSupplemental Content
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or sense of autonomy.
There is compelling evidence that both hedonic and
eudaimonic well-being are positively associated with lon-
gevity. In a systematic review of studies into the relation be-
tween hedonic well-being and longevity, Chida and Steptoe
(7) found that positive affect and positive trait-like dispositions
predicted longevity after controlling for negative affect,
demographic, and health behavior variables. A similar pat-
tern has been reported regarding the association between
eudaimonic well-being and longevity (8,9).
These findings have inspired investigation of the associ-
ation between well-being and incidence of chronic disease.ent of Psychology (Okely, Gale), University of Edinburgh, Edinburgh, UK;
uthampton, UK.
, MRC Lifecourse Epidemiology Unit, Southampton General Hospital,
2015.
ution License 4.0 (CCBY), which permits unrestricted use, distribution, and
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ORIGINAL ARTICLEGreater well-being has been linked with lower incidence of
cancer, and breast cancer specifically (10,11), Type 2 diabe-
tes (10,12), and cardiovascular disease (13,14). However,
the evidence is inconsistent: other studies have reported
no relation between well-being and breast cancer (15) or
heart disease (10,16). This line of investigation has raised
the question of whether the association between well-
being and disease risk is similar across different diseases.
Many chronic diseases share several risk factors, but it is
unclear whether chronic diseases share another risk factor
in the form of well-being. Richman et al. (17) have argued
that well-being may provide a “broad base of resilience”
against chronic disease. However, Diener and Chan (18)
suggested that as different types of disease involve different
physiological processes and causes, the strength of associa-
tion between well-being and disease risk is likely to vary
across different types of diseases—with some having little
or no association with prior well-being.
Research investigating the association between well-
being and multiple disease outcomes is sparse. One study
investigating the association between positive emotion
and respiratory tract infection, diabetes, and hypertension
found a significant association in the case of incident hyper-
tension but not for incident diabetes or respiratory tract in-
fection (after adjusting for established risk factors) (17).
However, it is unclear whether well-being was differentially
related to these disease outcomes because the studywas sig-
nificantly underpowered. Another, larger study (10) found
no significant relationship between well-being and myocar-
dial infarction but greater well-being was associated with a
reduced risk of cancer, diabetes, and stroke. In the current
study, we aimed to extend this area of research by compar-
ing the association between well-being and disease risk
across a greater number of chronic diseases. We used data
from the English Longitudinal Study of Ageing (ELSA), a
population-based sample of men and women 50 years and
older. The sample includes data on the incidence of a range
of chronic diseases. Disease outcomes included in the cur-
rent study were stroke, myocardial infarction, diabetes, ar-
thritis, chronic lung disease, and cancer.METHODS
Study Population
The ELSA is a prospective study of people 50 years and older. Participants
were initially recruited from the Health Survey for England database in
1998, 1999, and 2001. At Wave 1 (2002–2003), 12,099 people participated;
since then, participants have been interviewed biennially. Ethical approval
was provided by the London Multicentre Research and Ethics Committee.
Participants gave written informed consent (19).
Well-Being and Chronic Disease Incidence
Well-being at Wave 1 was assessed with the CASP-19 quality of life ques-
tionnaire that assesses the domains of control, autonomy, self-realization,
and pleasure (20). Participants respond to 19 questions on a 4-point LikertPsychosomatic Medicine, V 00 • 00-00 2
Copyright © 2015 by the American Psychosomatic Society.scale (scored 0-3). Possible total scores range from 0 to 57, with higher
scores indicating higher levels of well-being. For individuals with 4 or
fewer CASP-19 items missing, we imputed a score for the missing items
based on their mean score for the completed items. For the study sample,
internal consistency for CASP-19 scores was high (α = 0.87).
AtWave 1, participants were askedwhether a doctor had ever told them
that they had any of the following conditions: high blood pressure/
hypertension, myocardial infarction, diabetes or high blood sugar, a stroke,
chronic lung disease, arthritis or rheumatism, or cancer. Participants re-
ported the month and year of diagnosis. In subsequent waves (2–5), partic-
ipants were presented with the same list and asked whether they had been
diagnosed as having any of the listed conditions since their last inter-
view, and if so, what date this occurred. Data regarding time of diagnosis
were not available for chronic lung disease. Instead, time of diagnosis was
indexed as the time of the interview (month and year) at which the partic-
ipant first reported a diagnosis of chronic lung disease.
Covariates
We chose age, sex, depressive symptoms, socioeconomic status, education,
and relationship status as potential confounders and health behaviors (phys-
ical activity, alcohol consumption, and smoking status), and bodymass index
(BMI) as mediators of the relationship between well-being and later disease
incidence. Feller et al. (10) found that adjusting for health behaviors, BMI,
and education attenuated the association between life satisfaction and disease
incidence. Socioeconomic status, depressive symptoms, and age have been
associated with well-being as well as incidence of chronic disease (5,21–26).
The eight-item version of Centre for Epidemiological Studies Depression
Scale (CES-D) was used to assess symptoms of depression (27). Socioeco-
nomic status was indexed by total household wealth; household wealth has
been identified as themost accurate indicator of long-term socioeconomic cir-
cumstances in ELSA (28). Education was based on highest reported level of
qualification: less than O level or equivalent, O level or equivalent, A level or
equivalent, higher thanA level but below degree, and degree level (American
equivalent qualifications are high school diploma forO level and 1-year study
at college with a B average for A level). Relationship status was dichoto-
mized as having a partner (yes or no). Participants reported the frequency
with which they engaged in vigorous, moderate, and mild exercise. Re-
sponse options were “more than once a week,” “once a week,” “one to
three times a month,” and “hardly ever or never.” As previously (29), re-
sponses were dichotomized—either once a week (or more) or less than
once a week—and then summed to create four categories: physical inactivity,
mild but not moderate/vigorous activity, moderate but not vigorous physical
activity, and vigorous physical activity. Frequency of alcohol consumption
was recorded. Response options were as follows: twice a day ormore, daily
or almost daily, once or twice a week, once or twice a month, special occa-
sions only, and not at all. Participants reported their smoking status.
Analytical Sample
Of the 12,099 people taking part in Wave 1, 8182 were included in the cur-
rent analysis. Participants were excluded if they only took part in Wave 1
(n = 2121; 18%); they were additionally excluded if they had incomplete
(missing more than four items) or missing data for well-being (n = 886;
7%) and further excluded if they had missing data on any of the covariates
(n = 910; 8%). The median length of follow-up was 6 years; the last year of
assessment considered in this study was 2011.
Statistical Analysis
Cox proportional hazards regression was used to examine the association
between CASP-19 scores at baseline and incidence of diabetes, myocardial
infarction, stroke, cancer, chronic lung disease, and arthritis. On the basis of
Schoenfeld residuals, we found no evidence that the proportional hazards
assumption was violated (all p values > .2). Survival time in days was cal-
culated from the date of the Wave 1 interview to the date of diagnosis with
the disease of interest or the date of the last follow-up interview, whicheverMonth 2016
 Unauthorized reproduction of this article is prohibited.
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Copyright © 2015 by the American Psychosomatic Society.occurred first. Participants diagnosed as having the disease of interest at
Wave 1 were excluded from the analysis. Four models were used, in which
we first adjusted for potential confounding factors (Models 1-3) and then in
addition for potential mediating factors (Model 4). Model 1 adjusted for age
and sex. Model 2 additionally adjusted for total household wealth, relation-
ship status, and education, and where appropriate, for comorbidities present
at Wave 1, such that for the outcome of diabetes, Model 2 adjusted for re-
ported hypertension; for myocardial infarction and stroke, Model 2 adjusted
for reported diabetes and hypertension; and for chronic lung disease,Model 2
adjusted for reported asthma. Model 3 additionally adjusted for CES-D
score. Model 4 additionally adjusted for health behaviors and BMI. Hazard
ratios (HRs) and 95% confidence intervals (CIs) for each chronic disease
are expressed according to a standard deviation (SD) increase in CASP-19
score. To test for age or sex differences in the association between
CASP-19 score and disease risk, we entered multiplicative interaction
terms (e.g., CASP-19 by age) in an age- and sex-adjusted model. To reduce
the risk of reverse causality (i.e., undiagnosed preexisting disease influenc-
ing well-being), for outcomes that remained significantly associated with
CASP-19 scores in the fully adjusted model, the regression was repeated
excluding the first 2 years of follow-up.
We carried out additional Cox regression analyses of incident disease in
which we treated well-being and appropriate covariates (health behaviors,
depressive symptoms, relationship status, and BMI) as time varying, using
variables derived from data atWaves 1 to 4, to account for possible changes
in well-being and covariates over follow-up.
RESULTS
Table 1 shows the baseline characteristics of the sample ac-
cording to tertiles of well-being. On average, people with
higher well-being were younger, had lower CES-D scores,
were wealthier, had lower BMI, were more physically ac-
tive, consumed more alcohol, and had a higher level of ed-
ucation. People with higher well-being were also more
likely to be female, in a relationship, not to smoke, and less
likely to report a history of arthritis, diabetes, myocardial
infarction, hypertension, chronic lung disease, and stroke.
Preliminary analysis indicated that the relationship be-
tween CASP-19 scores and chronic disease incidence did
not differ according to sex (p for interaction terms all
>.05). The relationship between CASP-19 and incidence
of diabetes, myocardial infarction, and chronic lung disease
did differ significantly by age. In the case of these three dis-
ease outcomes, separate Cox proportional hazards regres-
sion analysis was conducted for two age groups (<65 and
≥65 years).
Estimates from models that used time-varying measures
of well-being and the covariates were very similar to those
obtained using the measure of well-being at one time point
(Wave 1) only, so only results from these latter analyses are
presented here (see Table S1, Supplemental Digital Content 1,
http://links.lww.com/PSYMED/A261, for a comparison
of results).
Table 2 displays the HRs for incident arthritis, cancer,
stroke, diabetes, myocardial infarction, and chronic lung dis-
ease according to an SD increase in overall CASP-19 score.
Nine hundred thirty-six incident cases of arthritis were
reported during follow-up. There was a significant inverse
association between CASP-19 scores and arthritis risk. ThisMonth 2016
 Unauthorized reproduction of this article is prohibited.
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ORIGINAL ARTICLErelationship remained significant (although attenuated) af-
ter adjusting for potential confounding variables (wealth,
education, relationship status, and CES-D score). Adjusting
for potential mediating variables (health behaviors and
BMI) did not attenuate this association further. The HR in
the fully adjusted model was 0.89 (95% CI = 0.83–0.96).
Three hundred ninety-five new cases of cancer were re-
ported. No significant association was found between
CASP-19 scores and incidence of cancer.
Two hundred fifty-eight new cases of stroke were re-
ported. A significant association between CASP-19 scores
and incidence of stroke was only observed in Model 1 (ad-
justed for age and sex) with an SD increase in CASP-19
score associated with an HR of 0.84 (95% CI = 0.75–0.95).
This association was of borderline significance (p = .08) af-
ter adjustments for the potential confounding variables in
Model 2. Further adjustment for depressive symptoms and
the potential mediating variables attenuated the association
still further.
Four hundred fifty-one cases of incident diabetes were
reported during follow-up. Analysis stratified by age group
indicated a trend for a stronger association between CASP-19
scores and incident diabetes at a younger age. In the <65-year
age group, a significant inverse association between CASP-19
score and diabetes risk was observed in all four models. The
association was attenuated by adjusting for potential con-
founding variables but remained statistically significant
(HR = 0.77, 95% CI = 0.67–0.89). Further adjustment for
the potential mediating factors suggested that these vari-
ables explained 21% of the association. No significant asso-
ciation was observed for the ≥65-year age group.
One hundred eighty-five new cases of myocardial in-
farction were reported. There was a trend for a stronger
association between CASP-19 scores and incident myocar-
dial infarction at a younger age. A significant inverse asso-
ciation between CASP-19 scores and myocardial infarction
risk was observed for both age groups. In Model 2, an SD
increase in CASP-19 score was associated with a decrease
in myocardial infarction risk (HR = 0.74, 95% CI = 0.59–
0.94) for the <65-year age group and a decrease in myocar-
dial infarction risk in the ≥65-year age group (HR = 0.81,
95% CI = 0.68–0.97). This association was of borderline
significance after adjusting for depressive symptoms in
Model 3 for the <65-year age group (p = .07) and the
≥65-year age group (p = .06). The association was further
attenuated by adjusting for potential mediating variables
in Model 4.
Three hundred two new cases of chronic lung disease
were reported. There was a trend for a stronger association
between CASP-19 scores and incident lung disease at
younger ages. In those younger than 65 years, a significant
inverse association between CASP-19 scores and chronic
lung disease risk was observed in all four models. In
Model 3, an SD increase in CASP-19 score was associatedPsychosomatic Medicine, V 00 • 00-00 6
Copyright © 2015 by the American Psychosomatic Society.with an HR of 0.76 (95% CI = 0.63–0.92). Adjusting for
potential mediating variables in Model 4 attenuated the as-
sociation by 16%. In Model 2, for the ≥65-year age group,
an SD increase in CASP-19 score was associated with an
HR of 0.80 (95% CI = 0.68–0.95). The association was
of borderline significance in Model 3 (p = .06) and was
further attenuated by adjusting for health behaviors and
BMI in Model 4.
We carried out several sensitivity analyses. We tested
whether exclusion of participants with missing covariate
data had biased the results. For each disease outcome, the
age- and sex-adjusted model was rerun including partici-
pants with missing covariate data. The results were very
similar to those obtained in the sample with complete data
indicating that the exclusion of participants with missing
covariate data did not significantly affect the results. We
also tested for bias due to the exclusion of participants with
missing CASP-19 data. In an age- and sex-adjusted model,
missing well-being data did not predict incident arthritis,
stroke, diabetes, or myocardial infarction; however, partici-
pants with missing well-being data were significantly more
likely to develop chronic lung disease and were less likely
to be diagnosed as having cancer. We carried out additional
sensitivity analyses for the three chronic conditions that
were significantly associated with well-being in the fully
adjusted model: arthritis, diabetes (for those <65 years of
age) and chronic lung disease (for those <65 years of
age). Firstly, we repeated the analysis excluding cases diag-
nosed in the first 2 years of follow-up. The association be-
tween well-being and risk of arthritis and diabetes was
slightly changed suggesting that the association is unlikely
to reflect reverse causation whereby undiagnosed disease at
baseline affected well-being. However, the association be-
tween well-being and chronic lung disease incidence was
no longer significant. The fully adjusted HRs for arthritis,
diabetes, and chronic lung disease were 0.87 (95% CI =
0.79–0.96), 0.84 (95% CI = 0.70–1.00), and 0.85 (95%
CI = 0.67–1.08), respectively. Three hundred fifty-three
cases of incident arthritis, 62 cases of diabetes, and 53 cases
of chronic lung disease were excluded from this sensitivity
analysis. Second, we repeated the analysis using an
amended CASP-19 score that excluded two items that refer
either specifically to health (“my health stops me from do-
ing the things I want to do”) or to age-related problems that
might be interpreted by the respondent to include health
(“my age prevents me from doing the things I would like
to do") to check whether they inflated the associations we
found between well-being and disease risk. When both
items were excluded from the CASP-19 score, fully ad-
justed HRs remained significant for the outcomes of arthri-
tis and chronic lung disease (0.92 [95% CI = 0.85–0.99]
and 0.82 [95% CI = 0.68–0.99], respectively) and were of
borderline significance in the case of diabetes (HR = 0.86
[95% CI = 0.74–1.00]). These estimates are very similarMonth 2016
 Unauthorized reproduction of this article is prohibited.
Well-Being and Chronic Disease Incidenceto those obtained using the original CASP-19 score, although
the HR for diabetes is slightly weaker.DISCUSSION
In this study of people 50 years and older, those with greater
well-being at baseline had a lower risk of incident disease.
However, the extent of this association differed according
to type of disease and, in some cases, age group. Incident
arthritis, diabetes, and chronic lung disease were associated
with CASP-19 scores after adjusting for confounding vari-
ables; in the case of diabetes and chronic lung disease, the
association was partially mediated by health behaviors
and BMI. The risk association for myocardial infarction
remained significant after adjusting for demographic vari-
ables and comorbidity but became of borderline signifi-
cance after adjusting for depressive symptoms and was no
longer significant after adjusting for health behaviors and
BMI. For the outcome of stroke, this association became
nonsignificant after adjusting for demographic variables,
comorbidity, and depressive symptoms. No association was
observed for cancer incidence. An age interaction was ob-
served for diabetes, myocardial infarction, and chronic lung
disease, with a stronger association between CASP-19
score and disease incidence at younger ages.
This is the first study to report an association between
well-being and risk of incident arthritis. The relationship
between psychological factors and the onset of arthritis
has received little empirical attention (30). However, one
longitudinal study has reported a positive association be-
tween perceived stress and onset of arthritis 3 years later
(31). Examination of the four analytical models suggests
that the association between well-being and arthritis risk
is partially confounded by demographic variables and de-
pressive symptoms. The association was not explained by
the potential mediating factors, health behaviors, and
BMI. This suggests that additional mechanisms (not con-
trolled for in our model) are involved in the association be-
tween well-being and arthritis risk. Well-being may have an
effect on physiological processes relevant to arthritis risk or
symptom expression. Higher well-being is associated with
a reduced inflammatory response (32,33). Thus, well-being
might lessen the expression of arthritic symptoms by reduc-
ing the extent of inflammation.
In the present study, we found no significant association
between CASP-19 scores and incident cancer. Our results
are in line with two studies that reported no association be-
tween life satisfaction and breast cancer (15) and life satis-
faction and cancer as a whole in men (10). However, our
findings contradict reports of a significant association be-
tween well-being and cancer in women (10) and breast
cancer specifically (11). It is possible that well-being is as-
sociated with particular types of cancer. It has been sug-
gested that psychological factors such as stress andPsychosomatic Medicine, V 00 • 00-00 7
Copyright © 2015 by the American Psychosomatic Society.depression specifically increase the risk of virus-related
cancers (29,34). We were unable to discriminate between
different types of cancers in our analysis, and thusmay have
missed these specific associations.
Higher CASP-19 scores were associated with a de-
creased risk of incident stroke in the age- and sex-adjusted
model. This association did not persist after adjustment
for demographic variables and prevalent hypertension and
diabetes. Some studies have reported a similar attenuation
after adjusting for established risk factors in the case of
cardiovascular disease incidence (35,36) and stroke (10).
However, others have reported a significant association be-
tween positive affect and incident stroke after adjusting for
demographic factors, prevalent diabetes, hypertension, and
health behaviors (37). Difference in sample age (all >65 years)
and the inclusion of fatal stroke cases could explain why this
latter study found a stronger association than that found here.
We found a significant association between CASP-19
scores and myocardial infarction risk after adjusting for de-
mographic variables in both age groups. The association
was of borderline significance after adjusting for depressive
symptoms and further attenuated after adjusting for mediat-
ing variables. Two studies have reported a significant asso-
ciation between well-being and incident coronary heart
disease after adjusting for established risk factors (14,38);
neither study adjusted for the potential mediating effect of
physical activity. Feller et al. (10) found no significant asso-
ciation between life satisfaction and incident myocardial in-
farction. The authors suggest that this null finding may be
due to a low number of cases in their sample. The current
results support findings indicating an association between
well-being andmyocardial infarction risk (14,38); however,
our results suggest that this association is predominantly
confounded by depressive symptoms andmediated by health
behaviors and BMI.
Diabetes risk was significantly associated with CASP-19
score for the <65-year age group. This association remained
significant but attenuated in the fully adjusted model. In the
≥65-year age group, there was no association between
CASP-19 score and diabetes risk. A previous study has doc-
umented an association between well-being (emotional vital-
ity and life satisfaction) and physician-diagnosed diabetes
(39). In line with our results, this association remained signif-
icant after adjusting for demographic variables, health behav-
iors, BMI, and depressive symptoms. However, a second
study into the association between life satisfaction and diabe-
tes risk has documented a weaker association (10). Life satis-
faction was only associated with diabetes risk in women, and
this association was not significant after excluding incident
diabetes in the first 2 years and adjusting for established
risk factors and prevalent hypertension. Other psychologi-
cal factors (not controlled for in the current study) including
stress, anger, hostility, sleep problems, and anxiety have
been associated with incidence of diabetes. Feller et al.Month 2016
 Unauthorized reproduction of this article is prohibited.
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the influence of these psychosocial factors. Alternatively,
well-being may directly affect physiological processes rele-
vant to diabetes risk. For instance, elevated C-reactive pro-
tein previously associated with low well-being (40) is a
strong independent predictor of Type 2 diabetes (41).
For people younger than 65 years, higher well-being sig-
nificantly reduced the risk of chronic lung disease; this ef-
fect remained significant but attenuated after adjusting for
established risk factors. In the ≥65-year age group, this as-
sociation was no longer significant after adjusting for de-
pressive symptoms. This is the first study to document a
significant association between well-being and incidence
of chronic lung disease. Our results suggest that this associ-
ation is partially confounded by demographic variables,
history of asthma, and depressive symptoms and mediated
by health behaviors. However, additional factors appear
to play a role in the <65-year age group. Chronic inflam-
mation is central to the pathophysiology of chronic lung
diseases (42); thus, similarly to arthritis, well-being may af-
fect chronic lung disease risk via its association with the in-
flammatory response (32,40).
Our findings suggest that the strength of the association
between well-being and disease risk is disease dependent—
with no association found for cancer and the strongest asso-
ciations observed for arthritis, diabetes, and chronic lung
disease. It is unclear why this group of diseases has a stron-
ger association with well-being; however, the role of re-
verse causality should be considered. Compared with the
events of stroke and myocardial infarction, clinical diagno-
sis of arthritis, diabetes, and chronic lung disease may occur
sometime after disease onset. The stronger association be-
tween well-being and this group of diseases found in our
study may perhaps reflect the impact of undiagnosed symp-
toms at baseline on well-being. Although our results sup-
port the idea that well-being is differentially related to
different diseases, no previous studies have documented
this pattern of specificity. Feller et al. (10), who included
a number of the same disease outcomes as the current study
(diabetes, all-cause cancer, stroke, and myocardial infarc-
tion), report a different pattern of association (with the
strongest association between life satisfaction and disease
risk in women observed for cancer and stroke). Research in-
volving a comparable age group and well-being measure is
needed to confirm our findings.
The time-varying model produced similar estimates to
the original model (which used baseline measures of covar-
iates) for the association between overall CASP-19 scores
and disease risk. The small difference between the two
models may indicate that levels of well-being remained sta-
ble over time. The temporal stability of well-being has been
documented in a number of studies (43,44). In the current
sample, the test–retest correlation coefficient for CASP-19
scores at Wave 1 and Wave 5 was high: r = 0.62, p < .001.Psychosomatic Medicine, V 00 • 00-00 8
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chronic lung disease, we found that the association between
well-being and disease incidence tended to be stronger at
younger ages. A similar age interaction—with a stronger ef-
fect at younger ages—is reported by a study into the associ-
ation between life satisfaction and mortality (9). One
explanation for our observations is that individuals who
were particularly susceptible to the potentially detrimental
effects of low well-being on health did not survive to older
ages. In contrast with our results, two systematic reviews
indicated that the associations between well-being and mor-
tality or cardiovascular and physiological reactivity may, in
fact, be stronger at older ages (7,45). The cause of these di-
vergent findings is unclear; however, it is possible that the
effect of age is dependent on health outcome. Howell et al.
(45) did not find a significant age–well-being interaction in
the case of short-term immune functioning, endocrine re-
sponse, longevity, and symptom control.
Our study has some limitations. First, disease incidence
was assessed using a self-report measure; the validity of
self-report measures varies according to disease outcome.
Studies have reported high agreement between self-report
and clinically derived diagnosis in the case of cardiovascu-
lar diseases, diabetes (46), and cancer (47); lower levels of
agreement have been found for osteoarthritis (46) and respi-
ratory diseases (48), although others have demonstrated
that self-report measures provide a valid estimate of disease
prevalence for arthritis (49) and chronic lung disease (50).
Fatal disease incidence—particularly relevant in the case
of heart disease and stroke—was not recorded and therefore
could not be included in the analysis. Second, the effect of
potential bias due tomissing data cannot be ruled out as par-
ticipants with missing CASP-19 data were more likely to be
diagnosed as having chronic lung disease and less likely to
be diagnosed as having cancer. Third, the association be-
tween well-being and chronic lung disease was not signifi-
cant after excluding incident cases within the first 2 years of
follow-up suggesting an effect of reverse causation. How-
ever, the lower statistical power in this analysis (due to
the inclusion of fewer incident cases) could also account
for this result. Fourth, the CASP-19 has been criticized for
the inclusion of two items that refer specifically to health-
or to age-related problems that might be interpreted by the
respondent to include health (51). After removal of these
two items from the CASP-19 score, estimates for the asso-
ciations betweenwell-being and incident arthritis or chronic
lung disease were very similar to those obtained with the
original score, whereas that with diabetes incidence was
slightly weaker. This suggests that the inclusion of these
two health-related items in the CASP-19 is not having an
undue influence on our findings. Fifth, we were unable to
differentiate between different forms of cancer; different
forms of cancer vary significantly with regard to etiology
and time course and thus may be differentially related toMonth 2016
 Unauthorized reproduction of this article is prohibited.
Well-Being and Chronic Disease Incidenceprior well-being. Finally, a number of potentially relevant
covariates were not included in the analysis, namely, diet,
sleep quality, perceived stress, and anxiety. Strengths of
the study should also be noted. We were able to adjust for
potential confounders (including depression) and several
potentially important mediators. Additional strengths in-
cluded separate analysis across a range of disease outcomes
and the fact that the sample is representative of people older
than 50 years living in England (19).
To conclude, this study provides further evidence for the
health-protective effect of well-being in the case of disease
incidence. In addition to corroborating previous results re-
garding the association between well-being and incidence
of stroke, diabetes, and myocardial infarction, the study
demonstrates that this association extends to other chronic
conditions including arthritis and chronic lung disease. The
study illustrates how the association between well-being
and disease incidence varies according to the disease out-
come. Finally, the results provide further insight regarding
the mechanisms underlying the association between well-
being and disease incidence. Factors including health be-
haviors, BMI, depression, and demographic variables seem
to account for the association between well-being and inci-
dent myocardial infarction and stroke. Additional factors
may be implicated in the associations between well-being
and arthritis, diabetes, and chronic lung disease.
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